These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
390 related items for PubMed ID: 15472855
1. New developments in the diagnosis and management of posttransplantation lymphoproliferative disorders in solid organ transplant recipients. Preiksaitis JK. Clin Infect Dis; 2004 Oct 01; 39(7):1016-23. PubMed ID: 15472855 [Abstract] [Full Text] [Related]
2. Review of Epstein-Barr virus and post-transplant lymphoproliferative disorder post-solid organ transplantation. Lim WH, Russ GR, Coates PT. Nephrology (Carlton); 2006 Aug 01; 11(4):355-66. PubMed ID: 16889577 [Abstract] [Full Text] [Related]
3. Incidence and outcome of primary Epstein-Barr virus infection and lymphoproliferative disease in pediatric heart transplant recipients. Zangwill SD, Hsu DT, Kichuk MR, Garvin JH, Stolar CJ, Haddad J, Stylianos S, Michler RE, Chadburn A, Knowles DM, Addonizio LJ. J Heart Lung Transplant; 1998 Dec 01; 17(12):1161-6. PubMed ID: 9883755 [Abstract] [Full Text] [Related]
4. Presentation and early detection of post-transplant lymphoproliferative disorder after solid organ transplantation. Bakker NA, van Imhoff GW, Verschuuren EA, van Son WJ. Transpl Int; 2007 Mar 01; 20(3):207-18. PubMed ID: 17291214 [Abstract] [Full Text] [Related]
5. Posttransplant lymphoproliferative diseases. Gross TG, Savoldo B, Punnett A. Pediatr Clin North Am; 2010 Apr 01; 57(2):481-503, table of contents. PubMed ID: 20371048 [Abstract] [Full Text] [Related]
6. Diagnosis and management of posttransplant lymphoproliferative disorder in solid-organ transplant recipients. Preiksaitis JK, Keay S. Clin Infect Dis; 2001 Jul 01; 33 Suppl 1():S38-46. PubMed ID: 11389521 [Abstract] [Full Text] [Related]
10. Diagnosis of post-transplant lymphoproliferative disorder in solid organ transplant recipients - BCSH and BTS Guidelines. Parker A, Bowles K, Bradley JA, Emery V, Featherstone C, Gupte G, Marcus R, Parameshwar J, Ramsay A, Newstead C, Haemato-oncology Task Force of the British Committee for Standards in Haematology and British Transplantation Society. Br J Haematol; 2010 Jun 27; 149(5):675-92. PubMed ID: 20408847 [Abstract] [Full Text] [Related]
11. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center. Knight JS, Tsodikov A, Cibrik DM, Ross CW, Kaminski MS, Blayney DW. J Clin Oncol; 2009 Jul 10; 27(20):3354-62. PubMed ID: 19451438 [Abstract] [Full Text] [Related]
12. Epstein-Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course. Oertel S, Trappe RU, Zeidler K, Babel N, Reinke P, Hummel M, Jonas S, Papp-Vary M, Subklewe M, Dörken B, Riess H, Gärtner B. Ann Hematol; 2006 Jul 10; 85(7):478-84. PubMed ID: 16586109 [Abstract] [Full Text] [Related]
13. Posttransplant lymphoproliferative disorder. Everly MJ, Bloom RD, Tsai DE, Trofe J. Ann Pharmacother; 2007 Nov 10; 41(11):1850-8. PubMed ID: 17940127 [Abstract] [Full Text] [Related]
14. Post-transplant lymphoproliferative disorder. Basgoz N, Preiksaitis JK. Infect Dis Clin North Am; 1995 Dec 10; 9(4):901-23. PubMed ID: 8747772 [Abstract] [Full Text] [Related]
15. Evidence for genetic susceptibility towards development of posttransplant lymphoproliferative disorder in solid organ recipients. Babel N, Vergopoulos A, Trappe RU, Oertel S, Hammer MH, Karaivanov S, Schneider N, Riess H, Papp-Vary M, Neuhaus R, Gondek LP, Volk HD, Reinke P. Transplantation; 2007 Aug 15; 84(3):387-91. PubMed ID: 17700165 [Abstract] [Full Text] [Related]
16. B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders. Dolcetti R. Autoimmun Rev; 2007 Dec 15; 7(2):96-101. PubMed ID: 18035317 [Abstract] [Full Text] [Related]
17. Epstein-Barr virus (EBV) early-antigen serologic testing in conjunction with peripheral blood EBV DNA load as a marker for risk of posttransplantation lymphoproliferative disease. Carpentier L, Tapiero B, Alvarez F, Viau C, Alfieri C. J Infect Dis; 2003 Dec 15; 188(12):1853-64. PubMed ID: 14673764 [Abstract] [Full Text] [Related]
18. New approaches to posttransplant lymphoproliferative disorder (PTLD). Porcu P. Clin Adv Hematol Oncol; 2005 Jan 15; 3(1):24-6. PubMed ID: 16166963 [No Abstract] [Full Text] [Related]
19. Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients. San-Juan R, Comoli P, Caillard S, Moulin B, Hirsch HH, Meylan P, ESCMID Study Group of Infection in Compromised Hosts. Clin Microbiol Infect; 2014 Sep 15; 20 Suppl 7():109-18. PubMed ID: 24475976 [Abstract] [Full Text] [Related]
20. Posttransplantation lymphoproliferative disorder--the great mimic in liver transplantation: appraisal of the clinicopathologic spectrum and the role of Epstein-Barr virus. Koch DG, Christiansen L, Lazarchick J, Stuart R, Willner IR, Reuben A. Liver Transpl; 2007 Jun 15; 13(6):904-12. PubMed ID: 17539010 [Abstract] [Full Text] [Related] Page: [Next] [New Search]